Overview
No overview information available.
Background
No background information available.
Indication
用于冠心病、脑血栓、动脉粥样硬化。亦用于高血脂、高血压的辅助治疗。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
Mannitole Nicotinate Tablets | 国药准字H13024050 | 化学药品 | 片剂 | 9/29/2020 | |
Mannitole Nicotinate Tablets | 国药准字H33022122 | 化学药品 | 片剂 | 3/6/2020 | |
Mannitole Nicotinate Tablets | 国药准字H50021996 | 化学药品 | 片剂 | 8/17/2020 | |
Mannitole Nicotinate Tablets | 国药准字H11022339 | 化学药品 | 片剂 | 8/19/2020 | |
Mannitole Nicotinate Tablets | 国药准字H22024993 | 化学药品 | 片剂 | 1/20/2022 | |
Mannitole Nicotinate Tablets | 国药准字H32026036 | 化学药品 | 片剂 | 8/11/2020 | |
Mannitole Nicotinate Tablets | 国药准字H13023996 | 化学药品 | 片剂 | 8/25/2020 | |
Mannitole Nicotinate Tablets | 国药准字H37023621 | 化学药品 | 片剂 | 3/12/2020 | |
Mannitole Nicotinate Tablets | 国药准字H21023151 | 化学药品 | 片剂 | 6/4/2020 | |
Mannitole Nicotinate Tablets | 国药准字H35021480 | 化学药品 | 片剂 | 3/23/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |